open access

Vol 13, No 4 (2016)
Research paper
Get Citation

Psychometric properties of the polish version of Patient Health Questionnaire-9

Andrzej Kokoszka, Adam Jastrzębski, Marcin Obrębski
Psychiatria 2016;13(4):187-193.

open access

Vol 13, No 4 (2016)
Prace oryginalne - nadesłane

Abstract

INTRODUCTION: Depression is one of the most common mental disorders. The Patient Health Questionnaire-9 (PHQ-9) is among several screening tools that are most often used to diagnose depression. Just as many other measurement instruments, it was first developed in English and then translated into other languages; these translations are used in many countries without being evaluated in terms of their psychometric properties. The aim of this study was to assess the psychometric properties of the Polish version of the Patient Health Questionnaire- 9 for a population aged 18−60 years.

MATERIAL AND METHODS: This study was conducted among 99 patients (45 men and 54 women, mean age = 41; SD = 12.5) who filled out the Patient Health Questionnaire-9 (PHQ-9), the Beck Depression Inventory (BDI) and who were interviewed with the structured Mini International Neuropsychiatric Interview (MINI 5.0.0) and the Hamilton Depression Rating Scale (HDRS)

RESULTS: The PHQ-9 had very good reliability, with Cronbach’s alpha coefficient = 0.88. The sensitivity and specificity of PHQ-9 in detecting an episode of depression were 82% and 89%, respectively, with a cut-off > 12. Scores on the PHQ-9 were strongly correlated with scores on the Beck Depression Inventory (rho = 0.92, p < 0.001) and the Hamilton Depression Rating Scale (rho = 0.87, p < 0.001).

CONCLUSIONS: The Polish version of the PHQ-9 has very good psychometric properties and is an effective screening tool for detecting depression among individuals aged 18–60 years.

Abstract

INTRODUCTION: Depression is one of the most common mental disorders. The Patient Health Questionnaire-9 (PHQ-9) is among several screening tools that are most often used to diagnose depression. Just as many other measurement instruments, it was first developed in English and then translated into other languages; these translations are used in many countries without being evaluated in terms of their psychometric properties. The aim of this study was to assess the psychometric properties of the Polish version of the Patient Health Questionnaire- 9 for a population aged 18−60 years.

MATERIAL AND METHODS: This study was conducted among 99 patients (45 men and 54 women, mean age = 41; SD = 12.5) who filled out the Patient Health Questionnaire-9 (PHQ-9), the Beck Depression Inventory (BDI) and who were interviewed with the structured Mini International Neuropsychiatric Interview (MINI 5.0.0) and the Hamilton Depression Rating Scale (HDRS)

RESULTS: The PHQ-9 had very good reliability, with Cronbach’s alpha coefficient = 0.88. The sensitivity and specificity of PHQ-9 in detecting an episode of depression were 82% and 89%, respectively, with a cut-off > 12. Scores on the PHQ-9 were strongly correlated with scores on the Beck Depression Inventory (rho = 0.92, p < 0.001) and the Hamilton Depression Rating Scale (rho = 0.87, p < 0.001).

CONCLUSIONS: The Polish version of the PHQ-9 has very good psychometric properties and is an effective screening tool for detecting depression among individuals aged 18–60 years.

Get Citation

Keywords

PHQ-9, depression, psychometric properties

About this article
Title

Psychometric properties of the polish version of Patient Health Questionnaire-9

Journal

Psychiatria (Psychiatry)

Issue

Vol 13, No 4 (2016)

Article type

Research paper

Pages

187-193

Bibliographic record

Psychiatria 2016;13(4):187-193.

Keywords

PHQ-9
depression
psychometric properties

Authors

Andrzej Kokoszka
Adam Jastrzębski
Marcin Obrębski

References (34)
  1. Kessler RC, Petukhova M, Sampson NA, et al. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res. 2012; 21(3): 169–184.
  2. Kiejna A, Piotrowski P, Adamowski T, et al. Rozpowszechnienie wybranych zaburzeń psychicznych w populacji dorosłych Polaków z odniesieniem do płci i struktury wieku — badanie EZOP Polska. . Psychiatr. Pol. 2015; 49: 15–27.
  3. Parafianowicz K, Sicińska J, Moran A, et al. Współwystępowanie zaburzeń psychicznych w łuszczycy: doniesienie wstępne. . Psychiatr. Pol. 2010; 44: 119–126.
  4. Kokoszka A, Pouwer F, Jodko A, et al. Serious diabetes-specific emotional problems in patients with type 2 diabetes who have different levels of comorbid depression: a Polish study from the European Depression in Diabetes (EDID) Research Consortium. Eur Psychiatry. 2009; 24(7): 425–430.
  5. Yohannes AM, Willgoss TG, Baldwin RC, et al. Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles. Int J Geriatr Psychiatry. 2010; 25(12): 1209–1221.
  6. BECK AT, WARD CH, MENDELSON M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961; 4: 561–571.
  7. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999; 282(18): 1737–1744.
  8. Bonsignore M, Barkow K, Jessen F, et al. Validity of the five-item WHO Well-Being Index (WHO-5) in an elderly population. Eur Arch Psychiatry Clin Neurosci. 2001; 251: 27–31.
  9. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67(6): 361–370.
  10. Tomaszewski K, Zarychta M, Bieńkowska A, et al. Walidacja polskiej wersji językowej Patient Health Questionnaire-9 w populacji hospitalizowanych osób starszych. . Psychiatr. Pol. 2011; 45: 223–233.
  11. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). American Psychiatric Association, , Washington DC 2013.
  12. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001; 16(9): 606–613.
  13. Titov N, Dear BF, McMillan D, et al. Psychometric comparison of the PHQ-9 and BDI-II for measuring response during treatment of depression. Cogn Behav Ther. 2011; 40(2): 126–136.
  14. Löwe B, Spitzer RL, Gräfe K, et al. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses. J Affect Disord. 2004; 78(2): 131–140.
  15. Thibodeau M, Asmundson G. The PHQ-9 assesses depression similarly in men and women from the general population. Personality and Individual Differences. 2014; 56: 149–153.
  16. Simon GE, Rutter CM, Peterson Do, et al. Does response on the PHQ-9 Depression Questionnaire predict subsequent suicide attempt or suicide death? Psychiatr Serv. 2013; 64(12): 1195–1202.
  17. Amtmann D, Kim J, Chung H, et al. Comparing CESD-10, PHQ-9, and PROMIS depression instruments in individuals with multiple sclerosis. Rehabil Psychol. 2014; 59(2): 220–229.
  18. Hyphantis T, Kotsis K, Kroenke K, et al. ARISTEIA-ABREVIATE Study Group members. Lower PHQ-9 cutpoint accurately diagnosed depression in people with long-term conditions attending the Accident and Emergency Department. J Affect Disord. 2015; 176: 155–163.
  19. van Steenbergen-Weijenburg KM, de Vroege L, Ploeger RR, et al. Validation of the PHQ-9 as a screening instrument for depression in diabetes patients in specialized outpatient clinics. BMC Health Serv Res. 2010; 10: 235–240.
  20. Han C, Jo SA, Kwak JH, et al. Validation of the Patient Health Questionnaire-9 Korean version in the elderly population: the Ansan Geriatric study. Compr Psychiatry. 2008; 49(2): 218–223.
  21. Haddad M, Walters P, Phillips R, et al. Detecting depression in patients with coronary heart disease: a diagnostic evaluation of the PHQ-9 and HADS-D in primary care, findings from the UPBEAT-UK study. PLoS One. 2013; 8(10): e78493.
  22. Thombs BD, de Jonge P, Coyne JC, et al. Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA. 2008; 300(18): 2161–2171.
  23. Gilbody S, Richards D, Barkham M. Diagnosing depression in primary care using self-completed instruments: UK validation of PHQ-9 and CORE-OM. Br J Gen Pract. 2007; 57(541): 650–652.
  24. Arroll B, Goodyear-Smith F, Crengle S, et al. Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population. Ann Fam Med. 2010; 8(4): 348–353.
  25. Santos IS, Tavares BF, Munhoz TN, et al. [Sensitivity and specificity of the Patient Health Questionnaire-9 (PHQ-9) among adults from the general population]. Cad Saude Publica. 2013; 29(8): 1533–1543.
  26. Wang W, Bian Q, Zhao Y, et al. Reliability and validity of the Chinese version of the Patient Health Questionnaire (PHQ-9) in the general population. Gen Hosp Psychiatry. 2014; 36(5): 539–544.
  27. Suzuki K, Kumei S, Ohhira M, et al. Screening for major depressive disorder with the Patient Health Questionnaire (PHQ-9 and PHQ-2) in an outpatient clinic staffed by primary care physicians in Japan: a case control study. PLoS One. 2015; 10(3): e0119147.
  28. Lecrubier Y, Sheehan DV, Weiller E, et al. The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. European Psychiatry. 1997; 12(5): 224–231.
  29. Masiak M, Przychodzka-Masiak J. International Neuropsychiatric Version. Polish Version 5.0.0. Katedra i Klinika Psychiatrii Akademii Medycznej w Lublinie, Lublin 2002.
  30. Valiengo LCL, Goulart AC, de Oliveira JF, et al. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960; 23(7): 56–62.
  31. Pużyński S, Wciórka J. Narzędzia oceny stanu psychicznego. . In: Pużyński S, Wciórka J, Rybakowski J. ed. Psychiatria. Tom I. Wydawnictwo Urban & Partner Wrocław, Wrocław 2002: 435–526.
  32. López-Pina JA, Sánhez-Meca J, Rosa-Alcázar AI. Hamilton Depression Rating Scalefor Depression: a meta analytic reliability generalization study. Int. J. Clin. Health Psychol. 2009; 9: 143–159.
  33. Parnowski T, Jernajczyk W. Inwentarz Depresji Becka w ocenie osób zdrowych i chorych na choroby afektywne (ocena pilotażowa). . Psychiatr. Pol. 1977; 11: 417–425.
  34. Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin. Psychol. Rev. 1988; 88: 77–100.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest Via Medica sp. z o.o. sp. komandytowa, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl